Lobaplatin arrests cell cycle progression in human hepatocellular carcinoma cells
<p>Abstract</p> <p>Background</p> <p>Hepatocellular carcinoma (HCC) still is a big burden for China. In recent years, the third-generation platinum compounds have been proposed as potential active agents for HCC. However, more experimental and clinical data are warrante...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-10-01
|
Series: | Journal of Hematology & Oncology |
Online Access: | http://www.jhoonline.org/content/3/1/43 |